Study elucidates the use of anticoagulants to treat bleeding in patients with gastrointestinal cancers

By | June 5, 2021
A study by Mayo Clinic researchers provides some clarity in the use of direct oral anticoagulants (DOAC), such as apixaban and rivaroxaban, to treat acute venous thromboembolism (VTE) in patients with gastrointestinal cancers.